Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 458-468
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.458
Table 1 Baseline characteristics of patients in gastrointestinal stromal tumors group and gastric leiomyoma group
Characteristics
GIST group (n = 88), (%)
Gastric leiomyoma group (n = 56), (%)
P value
Gender (male/female)47/4153.4/46.618/3832.1/67.90.012a
Age (median)61.150.10.00a
ECOG0.31
08697.75292.8
111.135.3
211.111.7
Tumor location0.00a
Cardia33.42544.6
Fundus4652.22035.7
Body2730.7814.3
Antrum1213.635.3
Diameter0.122
≤ 2 cm1112.51425
2-5 cm5461.43257.1
≥ 5 cm2326.11017.9
Table 2 Inflammation indicators of the two groups

GIST (n = 88)
Gastric leiomyoma (n = 56)
t value
P value
PLR158.2 ± 8.7134.3 ± 6.22.2170.028a
NLR2.35 ± 0.171.68 ± 0.083.6170.00a
LMR5.76 ± 0.5610.82 ± 1.622.9560.004a
SII546.2 ± 49.3384.3 ± 22.12.9930.003a
Table 3 Logistic regression analysis results

Group
β
SE
Wald
P value
OR
95%CI
GenderMale----1-
Female1.5480.5487.970.0054.71.605-13.762
Age-0.0970.02416.93900.9070.866-0.950
Tumor locationsCardia----1-
Fundus-3.5010.80418.94800.030.006-0.146
Body-3.5720.85417.4820.0010.0280.005-0.150
Antrum-3.3151.03910.190.0010.0360.005-0.278
LMR0.0920.0424.7150.031.0961.009-1.191
Table 4 Subgroup analysis of low-risk gastrointestinal stromal tumors and gastric leiomyoma

Low-risk GIST (n = 56)
Gastric leiomyoma (n = 56)
t value
P value
PLR146.1 ± 9.9134.3 ± 6.20.9920.324
NLR2.17 ± 0.171.68 ± 0.082.4510.016a
LMR5.42 ± 0.3210.82 ± 1.623.2670.002a
SII484.5 ± 56.1384.3 ± 22.11.6610.101